Links
Objectives
- Identify the major controlling input for each cell cycle checkpoint
 - Discuss the role of cyclin-dependent kinases
 
Key Points
Regulation
- certain cell factors promote transition to division
- some proteins found to vary in level with cell cycle = cyclins
 - genetic mutants found that regulate progression = cdc’s (cell div cycle)
- many found to encode kinases, interact with cyclins = cdk’s
 
 
 - CDK’s
- cyclin-dependent kinases, partner with cyclins
 - regulated by phosphorylation, in turn phosphorylate targets
- enzymes required for cellular processes
 
 
 - checkpoints
- G1/S is primary
- external factors can influence
 - links cell division to growth and nutritional status
 - accumulation of G1 cyclins activate Cdc2 kinase, activates targets
 
 - G2/M
- M-phase promoting factors involved in this check
- Mitotic cyclin + Cdc2 kinase
 
 - integrity of DNA after replication critical
 
 - M-phase promoting factors involved in this check
 - Spindle
- tension on MT, chromosomes aligned at metaphase plate
- unclear how mechanical signaling occurs
 
 - anaphase-promoting complex (APC) result in cohesin breakdown
- marks securin for degradation, releases inhibition on separase
 
 
 - tension on MT, chromosomes aligned at metaphase plate
 
 - G1/S is primary
 - Growth factors
- proteins with specific cell surface receptors
 - often trigger MAP kinase cascades that lead to G1 cyclin expression
 - not all cells affected by all growth factors
 
 - p53 is a tumor suppressor
- monitors DNA integrity, induces repair enzymes or cell death
 
 - proto-oncogenes: normal genes that cancer-causing when mutated
- involved in signaling, either receptors or part of transduction
 
 
In-class Activities
Describe some features and characteristics of cells deficient in each of the cell cycle checkpoints. For example, what would a cell deficient in G1/S regulation be like? What would it have or lack?
Questions for Practice
- Which cell cycle checkpoint is most influenced by external factors? Why is this adaptive?
 - Predict the consequences of a mutation in mitotic cyclin OR p53 OR a proto-oncogene.